Gibson Christopher bought PACB

April 8, 2026 · Form 4 insider transaction

Gibson Christopher bought 57,473 shares of Pacific Biosciences of California, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
57,473
Price
$0.00
Total value
N/A
Role
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 8, 2026
Filing dateApril 10, 2026
Shares owned after111,386
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Mr. Gibson was elected to the Board of Directors on March 3, 2026. Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 3rd of each of 2027, 2028, and 2029, provided such Reporting Person continues to serve as a director through the applicable vesting dates.

View the original Form 4 on SEC EDGAR